Showing posts with label d&o claims. Show all posts
Showing posts with label d&o claims. Show all posts

Friday, September 22, 2017

‘Turbulent’ Time, Uncertainty for D&O Litigation After Trump Dismantles Regulations

President Trump’s push to greatly reduce federal regulation will not reduce litigation, according to experts speaking here at Advisen’s Executive Risk Insights Conference on September 13.

Trump’s commitment since taking office to eliminate 80 percent of federal regulations has created a “false sense of security” for directors and officers, said Paul Schiavone, regional head of financial lines and liability for North America at Allianz.

Schiavone said the Trump administration’s withdrawal or suspension of hundreds of pending regulations creates uncertainty for executives.


Chad Hemenway, ‘Turbulent’ time, uncertainty for D&O litigation after Trump dismantles regulations (September 14, 2017), available with subscription at Advisen Professional Front Page News.

Monday, February 20, 2017

Quarterly D&O Claims Trends: Q1 2017

April 27, 2017 (Thursday) at 11am ET

Advisen will host a webinar that examines the D&O claims trends for the first quarter of 2017. On April 27, Advisen’s Jim Blinn and a panel of experts will discuss the frequency and severity of securities suits in Q1 2017 and share their insights on emerging trends on securities litigation.

This is a free, one-hour webinar.


Advisen Ltd. (2017). Quarterly D&O Claims Trends: Q1 2017 [Webinar].

Wednesday, January 4, 2017

Quarterly D&O Claims Trends: 2016 Wrap Up

January 25, 2017 (Wednesday) at 11am ET

Advisen will host a webinar that examines the D&O claims trends for 2016 focusing on Q4. On January 25, RT ProExec’s Kevin LaCroix, Advisen’s Jim Blinn, and a panel of experts will discuss the frequency and severity of securities suits in Q4 2016 and provide an overview of 2016.

Panelists
The following panelists will participate in the webinar:

* Kevin LaCroix, RT ProExec, a division of RT Specialty, and author of the D&O Diary
* Jim Blinn, Executive Vice President, Information & Analytics Division, Advisen (moderator)

Webinar Topics
Topics to be discussed:

* Frequency and severity of securities suits in Q4 2016
* Suits by type
* Suits by sector
* Merger objectioncases

This webinar announcement originally appeared on www.AdvisenLtd.com


Advisen Ltd. January 2017. Quarterly D&O Claims Trends: 2016 Wrap Up [Webinar].

Friday, December 23, 2016

What’s Trending in Public D&O Liability Claims?

December 2016

Directors and officers liability insurance gained attention in the past decade after a spate of investigations and lawsuits involving corporate directors and officers.

According to Advisen and Nationwide, while the number of D&O losses has been declining, the severity of these losses has been increasing over the last few years.

In an infographic, they look at the latest trends in directors & officers liability insurance including merger objection, securities class action, and derivative shareholder action. They also examine the general composition of cases from 2011 to 2016.

Download a copy of the infographic and know the top types of D&O cases and the industries with the most number of D&O claims.

Nationwide. Advisen Ltd. December 2016. What’s Trending in Public D&O Liability Claims? [Infographic].

Thursday, January 7, 2016

Quarterly D&O Claims Trends: 2015 Wrap Up

January 26, 2016
11:00 am - 12:00 pm ET 

Advisen will host a webinar and write a white paper that examines the D&O claims trends for the fourth quarter of 2015. On January 26, RT ProExec’s Kevin LaCroix, Advisen’s Jim Blinn and a panel of experts will discuss the frequency and severity of securities suits in Q4 2015 and share their insights on emerging trends on securities litigation.

Panelists

The following panelists will participate in the webinar:
Kevin LaCroix, RT ProExec, a division of RT Specialty, and author of the D&O Diary
Jim Blinn, Executive Vice President, Information & Analytics Division, Advisen (moderator)

Thursday, July 30, 2015

The Biotech Industry: Sophisticated Buyers in a Challenging Class

A sophisticated buyer is one who understands risk and program structure, is transparent, and can have high-level conversations. This is how biotech industry insurance buyers were described by panelists on Advisen’s quarterly D&O Claims Trends webinar.

While it may sound more like a broker and underwriter dream than reality, it is one of the benefits of working with this challenging class, according to the panelists.


Bradford, Josh. ‘The Biotech Industry: Sophisticated buyers in a challenging class’. ©2015 Advisen Ltd. 31 July 2015.